Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity (SLEEVE)
Sponsor: Assistance Publique Hopitaux De Marseille
Terminated
Premature end of inclusion
Other terminated trials from Assistance Publique Hopitaux De Marseille
- Psoriasis · Phase PHASE4 · Feb 2024
- Persistent ARDS · Phase PHASE3 · Nov 2023
- Paraganglioma · Phase NA · Oct 2023
- Epilepsy · Phase NA · Jun 2023
- Preterm Infant · Phase NA · May 2023
See all terminations from Assistance Publique Hopitaux De Marseille
Other Bariatric Surgery trials with similar outcome
A NA clinical study on Bariatric Surgery and Morbid Obesity, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique Hopitaux De Marseille and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Terminated NA
-
Nov 2024 — May 2025 [monthly]
Terminated NA
Status: Unknown → Terminated
-
Sep 2024 — Nov 2024 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Jul 2019 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
May 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique Hopitaux De Marseille
For direct contact, visit the study record on ClinicalTrials.gov .